What is the outlook for Vertex Pharmaceuticals?

Could you please elaborate on the current outlook for Vertex Pharmaceuticals? Are there any promising drug candidates in their pipeline that could potentially drive growth in the near future? Additionally, how do they compare to their competitors in terms of market share and financial performance? Lastly, what are some potential risks or challenges that Vertex Pharmaceuticals may face in the coming years?